Sign inJoin waitlistJoin the waitlist

PM

Paul Mathew

Principal Investigator and Associate Professor, Department of Hematology-Oncology · Tufts Medical Center

Credentials: · · · ·

History

Tufts Medical Center
Present

Medical Oncology
1988–1990
Internal Medicine
1985–1988
Tufts University School of Medicine
1981–1985

Research

Platinum-based chemotherapy for variant castrate-resistant prostate cancer
Clinical Cancer Research · 2013 · 389 citations
Effects of blocking platelet-derived growth factor-receptor signaling in a mouse model of experimental prostate cancer bone metastases
Journal of the National Cancer Institute · 2003 · 222 citations
Androgen receptor-negative human prostate cancer cells induce osteogenesis in mice through FGF9-mediated mechanisms
Journal of Clinical Investigation · 2008 · 150 citations

Christopher Logothetis
20 papers
Lance Pagliaro
11 papers
Nizar Tannir
10 papers
Shi-Ming Tu
9 papers
Patricia Troncoso
7 papers
CR
Charles Ryan
6 papers
MM
Michael Morris
5 papers
TB
Tomasz Beer
5 papers
Andrew Levey
4 papers
Daniel Fein
4 papers · 3 as a fellow
Eric Jonasch
4 papers
Lesley Inker
4 papers

Clinical trials

Hormonal Ablation, Imatinib Mesylate and Docetaxel for Patients With Prostate Cancer
Principal investigator · Completed · Phase 2
M.D. Anderson Cancer Center
2003–2010
Docetaxel and Imatinib Mesylate in Treating Patients With Androgen-Independent Prostate Cancer and Bone Metastases That Progressed on the Docetaxel and Placebo Group of MDA-ID-030008
Study chair · Completed · Phase 2
M.D. Anderson Cancer Center
2003–2008
Docetaxel With or Without Imatinib Mesylate in Treating Patients With Androgen-Independent Prostate Cancer and Bone Metastases
Study chair · Completed · Phase 2
M.D. Anderson Cancer Center
2003–2008